This inventor holds 7 USPTO granted patents and 8 published patent applications and 7 EPO patents. Top assignee: Sanbio, Inc.. Active years: 2015-2022.
Company Filing History:
Years Active: 2015-2022
Title: Irina Aizman: Innovator in Cell Proliferation and Biologically Active Mixtures
Introduction
Irina Aizman is a prominent inventor based in Mountain View, CA (US). She has made significant contributions to the field of biotechnology, particularly in the stimulation of cell proliferation and the development of biologically active mixtures. With a total of 7 patents to her name, Aizman's work has the potential to impact therapeutic applications significantly.
Latest Patents
Among her latest patents is a groundbreaking invention titled "Methods and compositions for stimulation of cell proliferation and provision of biologically active mixtures of FGF2 isoforms." This patent discloses methods and compositions for providing mixtures of FGF2 isoforms that are biologically active. The biological activities include stimulation of proliferation of neural precursor cells, endothelial cells, and the development of both neural precursor cells and astrocytes. Another notable patent is "MSC growth predictor assays," which provides methods for selecting lots of bone marrow stromal cells (MSCs) with high proliferative capacity. These methods are particularly useful in the manufacture of therapeutic derivatives of MSCs.
Career Highlights
Irina Aizman is currently employed at Sanbio, Inc., where she continues to advance her research and innovations. Her work at Sanbio focuses on developing therapies that harness the power of stem cells for regenerative medicine. Aizman's expertise in cell biology and her innovative approaches have positioned her as a leader in her field.
Collaborations
Irina collaborates with talented professionals in her field, including Damien Bates and Keita Mori. These collaborations enhance her research and contribute to the development of innovative solutions in biotechnology.
Conclusion
Irina Aizman's contributions to the field of biotechnology through her patents and research at Sanbio, Inc. highlight her role as a key innovator in cell proliferation and biologically active mixtures. Her work continues to pave the way for advancements in therapeutic applications.